GRADUAL WITHDRAWAL OF DIAZEPAM AFTER LONG-TERM THERAPY
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
41 outpatients who were long-term consumers of diazepam in therapeutic dosage were gradually withdrawn from the drug over 3 months by stepwise reduction. In a double-blind procedure half the patients began withdrawal immediately and half after 8 weeks. Of 36 patients who completed treatment, 16 (44.4%) experienced true withdrawal phenomena on reducing their drugs, but 8 other patients had pseudo-withdrawal reactions at a time when their drug treatment was unchanged. The pseudo-withdrawal reactions consisted of an increase in anxiety symptoms only, whereas true withdrawal symptoms also included perceptual changes and psychotic symptoms. Examination of pharmacological and clinical predictors of withdrawal phenomena and later relapse showed that personality factors were the most important, patients with passive-dependent traits having a significantly greater prevalence of withdrawal reactions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The proportion of patients who experienced acute withdrawal in our findings ranged from approximately 44% [52] to 100% [61,62].”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [52]
In the citing paper
“Following the acute withdrawal period, the emergence of de novo symptoms, including akathisia, pelvic pain, tinnitus, suicidal ideation, reduced appetite, weight loss, perceptual disturbances, paresthesia, depersonalization, derealization, numbness, and involuntary movements have been reported [30,31,50,52,61].”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [52]
In the citing paper
“Muscular fasciculations, mood swings, depression [53], perceptual abnormalities, dysphoria [52], trembling, nausea, vomiting, palpitations [40], headache, sweating, sensory disturbances, fear, fatigue [30], enuresis, disinhibition, aggression, impaired memory, weight loss, and ataxia [46] were reported along with the more common acute withdrawal symptoms of insomnia, anxiety, and nervousness [40].”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [52]
In the citing paper
“Acute withdrawal symptoms occurred in up to 100% of participants from studies found in this scoping review [52,61,62], but prolonged symptoms were less frequently reported, occurring in approximately 30% of benzodiazepine patients [17,54,69].”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [52]
In the citing paper
“Even nomenclature was confusing, since it was unclear whether these protracted symptoms were a continuation of acute withdrawal, the unmasking of original symptoms, or an entirely new condition [17,52,69].”
From Long-term neurological consequences following benzodiazepine exposure: A scoping review (2025) · cites this paper as [52]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 19 · Cited by 271
Metadata
- Authors
- Tyrer, P., Owen, R., & Dawling, S.
- Affiliations
- Guy's Hospital (GB)
- ORCID
- Tyrer, Peter
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1983-06
- Volume
- 321
- Issue
- 8339
- Pages
- 1402-1406
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2038849376
- Cited by
- 271
- References
- 19
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 1 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 2
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- diazepam, benzodiazepine withdrawal, gradual dose reduction, anxiety symptoms, perceptual change, psychotic symptoms, relapse, personality traits
- MeSH terms
- Adult, Aged, Clinical Trials as Topic, Diazepam, Double-Blind Method, Female, Humans, Male, Middle Aged, Personality, Substance Withdrawal Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GRADUAL WITHDRAWAL OF DIAZEPAM AFTER LONG-TERM THERAPY. https://app.cochat.ai/papers/10.1016/s0140-6736(83)92355-3
- The paper
- Tyrer, P., Owen, R., & Dawling, S. (1983). GRADUAL WITHDRAWAL OF DIAZEPAM AFTER LONG-TERM THERAPY. The Lancet. https://doi.org/10.1016/s0140-6736(83)92355-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.